Home | For Investors | Investors Information

Investors Information


SomnoMed Receives FDA Approval for New SMH Biomaterial



SomnoMed Annual Reports 

SomnoMed Annual Report 2009
SomnoMed Annual Report 2008

SomnoMed Annual Report 2007
SomnoMed Annual Report 2006
SomnoMed Annual Report 2005
SomnoMed Annual Report 2004



Analyst Research   

  30 July 2008 - Baillieu Research 


SomnoMed ASX Announcements

 For a complete list of all ASX Announcements visit SomnoMed Company Information on ASX 

22 July 2010 - USA Management Changes
14 July 2010 - SomnoMed expands business and opertions in Europe
30 June 2010 - SomnoMed Introduces new Medical Product
30 October 2009 - 4C Quarterly Report
26 October 2009 - SomnoMed now profitable
6 October 2009 -  SomnoMed welcomes ResMed’s entry into the oral appliance market
20 August 2009  - Investors presentation
30 June 2009 - Preliminary Final Report 2009
17 June 2009 -  SLEEP 2009 - Seattle
27 April 2009 -  Investors Presentation
27 April 2009 - March 09 update
31 March 2009 - Appendix 4C quaterly report 
16 February 2009 - SomnoMed enters Japan
31 December 2008 -  Appendix 4D and Half-Year Financial Report 31 December 2008
22 December 2008 - Change of Director's interest notice
7 September 2008 - Granted European patent
27 October 2008 - Growth continues unabated
27 October 2008 - Quaterly cash flow
15 October 2008 - New issue announcement
11 September 2008 - SomnoMed Investor Presentation 2008
28 August 2008 -  ASX Preliminary final report – 30 June 2008
28 July 2008 - SomnoMed USA subsidiary achieves fourth quarter profitability
28 July 2008 -  Quarterly report for entities admitted on the basis of commitments
10 June 2008 -  Investor Update
30 April 2008 - Quarterly Report
30 April 2008 -  SomnoMed accelerates third quarter global unit sales
19 March 2008 - SomnoMed Appoints Four Distribution Partners in Europe
18 March 2008 -  Change of Director’s Interest Notice
17 March 2008 - SomnoMed to Benefit from US Medicare decision
25 February 2008 - SomnoMed Half Year Financial Report
25 February 2008 - SomnoMed Unit Sales up 56% – strongest growth in US
1 January 2008 -  SomnoMed Receives FDA Approval for New SMH Biomaterial
18 December 2007 - SomnoMed signs License Agreement for the USA
12 November 2007 -  SomnoMed Appoints Head for European Operation
31 October 2007 - SomnoMed First Quarter up 34% Due to Jump in US Sales
5 October 2007 - Share Placement and Share Purchase Plan
30 August 2007 -  ASX Preliminary Final Report  30 June 07
1 August 2007 -  SomnoMed Acquires interest in Swiss Bio Plastic Venture
11 July 2007 - New SomnoMed CEO Appointment
5 June 2007 - SomnoMed European Expansion

                                            
                    


Subscribe for newsletter updates